These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 20432790

  • 21. [Heart failure: critical patients].
    Fabbri G, Gorini M, Maggioni AP, Oliva F, ANMCO.
    G Ital Cardiol (Rome); 2007 Sep; 8(9):568-73. PubMed ID: 17972426
    [Abstract] [Full Text] [Related]

  • 22. Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease.
    Egred M, Shaw S, Mohammad B, Waitt P, Rodrigues E.
    QJM; 2005 Jul; 98(7):493-7. PubMed ID: 15955798
    [Abstract] [Full Text] [Related]

  • 23. [Cardiovascular comorbidity in COPD].
    Cataluña JJ, García MA.
    Arch Bronconeumol; 2009 Jul; 45 Suppl 4():18-23. PubMed ID: 20116745
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Q: Can patients with COPD or asthma take a beta-blocker?
    Navas EV, Taylor DO.
    Cleve Clin J Med; 2010 Aug; 77(8):498-9. PubMed ID: 20682511
    [No Abstract] [Full Text] [Related]

  • 30. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD.
    Huang YL, Lai CC, Wang YH, Wang CY, Wang JY, Wang HC, Yu CJ, Chen L.
    Int J Chron Obstruct Pulmon Dis; 2017 Aug; 12():2987-2996. PubMed ID: 29066880
    [Abstract] [Full Text] [Related]

  • 31. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
    Decramer M, Rennard S, Troosters T, Mapel DW, Giardino N, Mannino D, Wouters E, Sethi S, Cooper CB.
    COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Differences among beta-blockers for the treatment of patients with heart failure and chronic obstructive pulmonary disease].
    Di Tano G, Frattini S, Pirelli S.
    G Ital Cardiol (Rome); 2011 Sep; 12(9):588-95. PubMed ID: 21892219
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonists.
    Hawkins NM, Petrie MC, Macdonald MR, Jhund PS, Fabbri LM, Wikstrand J, McMurray JJ.
    J Am Coll Cardiol; 2011 May 24; 57(21):2127-38. PubMed ID: 21596228
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations.
    Mersfelder TL, Shiltz DL.
    Ann Pharmacother; 2019 Dec 24; 53(12):1249-1258. PubMed ID: 31271049
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.